PAVmed (PAVM) Other Non-Current Liabilities (2023 - 2025)

PAVmed has reported Other Non-Current Liabilities for 3 years, with the latest figure at $6.9 million in Q3 2025.

• For the quarter ending Q3 2025, Other Non-Current Liabilities changed N/A year-over-year to $6.9 million; the trailing twelve-month figure through Sep 2025 stood at $6.9 million (changed N/A YoY), and the FY2024 full-year result was $29.1 million, down 34.16% from the prior year.
• Other Non-Current Liabilities for Q3 2025 stood at $6.9 million, up from $6.8 million in the prior quarter.
• The five-year high for Other Non-Current Liabilities was $44.2 million in Q4 2023, with the low at $260000.0 in Q2 2023.
• Average Other Non-Current Liabilities over 3 years is $13.5 million, with a median of $6.8 million recorded in 2025.
• Peak annual rise in Other Non-Current Liabilities reached 34.16% in 2024, while the deepest fall reached 34.16% in 2024.
• Tracing PAVM's Other Non-Current Liabilities over 3 years: stood at $44.2 million in 2023, then sank by 34.16% to $29.1 million in 2024, then sank by 76.29% to $6.9 million in 2025.
• The last three Other Non-Current Liabilities figures came in at $6.9 million (Q3 2025), $6.8 million (Q2 2025), and $6.6 million (Q1 2025), per Business Quant data.

Peer Comparison